Evidence map›Paper›PMID 31719238›Full record

ReviewNeural regeneration research2020

Edible seaweed-derived constituents: an undisclosed source of neuroprotective compounds.

Melissa Schepers, Nikita Martens, Assia Tiane, Kenneth Vanbrabant, Hong-Bing Liu, Dieter Lütjohann, Monique Mulder, Tim Vanmierlo

Erratum issuedOpen access · goldAbstract readReview
In one paragraph

Review in Neural regeneration research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 62 citations in OpenAlex.

  1. The Effect ofNutrients · 2024
    Trial
  2. Review
  3. The brown algaResearch in pharmaceutical sciences · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Sargachromenol Isolated fromMarine drugs · 2022
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Melissa SchepersDepartment of Neuroimmunology, Biomedical Research Institute, Hasselt University, European Graduate School of Neuroscience (EURON), Hasselt, Belgium; Department of Psychiatry & Neuropsychology, Division of Translational Neuroscience, School for Mental Health and Neuroscience, Maastricht University, European Graduate School of Neuroscience (EURON), Maastricht, The Netherlands.
Nikita MartensDepartment of Internal Medicine, Laboratory of Vascular Medicine, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Assia TianeDepartment of Neuroimmunology, Biomedical Research Institute, Hasselt University, European Graduate School of Neuroscience (EURON), Hasselt, Belgium; Department of Psychiatry & Neuropsychology, Division of Translational Neuroscience, School for Mental Health and Neuroscience, Maastricht University, European Graduate School of Neuroscience (EURON), Maastricht, The Netherlands.
Kenneth VanbrabantDepartment of Neuroimmunology, Biomedical Research Institute, Hasselt University, European Graduate School of Neuroscience (EURON), Hasselt, Belgium; Institue for Clinical Chemistry and Clinical Pharmacology, Bonn, Germany.
Hong-Bing LiuKey Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, Shandong Province, China.
Dieter LütjohannInstitue for Clinical Chemistry and Clinical Pharmacology, Bonn, Germany.
Monique MulderDepartment of Internal Medicine, Laboratory of Vascular Medicine, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Tim VanmierloDepartment of Neuroimmunology, Biomedical Research Institute, Hasselt University, European Graduate School of Neuroscience (EURON), Hasselt, Belgium; Department of Psychiatry & Neuropsychology, Division of Translational Neuroscience, School for Mental Health and Neuroscience, Maastricht University, European Graduate School of Neuroscience (EURON), Maastricht, The Netherlands.
Erasmus MC · NLEuropean Graduate School of Neuroscience · NLHasselt University · BEOcean University of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Edible marine algae, or seaweeds, are a rich source of several bioactive compounds including phytosterols, carotenoids, and polysaccharides. Over the last decades, seaweed-derived constituents turned out to not only reside in the systemic circulation, but are able to cross the blood-brain barrier to exert neuro-active functions both in homeostatic and pathological conditions. Therefore, seaweed-derived constituents have gained increasing interest for their neuro-immunomodulatory and neuroprotective properties, rendering them interesting candidates for the management of several neurodegenerative disorders. In particular seaweed-derived phytosterols gained interest for the treatment of neurodegenerative disorders as they potentiate neuroplasticity, enhance phagocytic clearance of neurotoxic peptides and have anti-inflammatory properties. Though, the anti-inflammatory and anti-oxidative properties of other constituents including carotenoids, phenols and polysaccharides have recently gained more interest. In this review, we provide an overview of a selection of the described neuro-active properties of seaweed-derived constituents with a focus on phytosterols.

Indexed as

algaecarotenoidsneuro-activephenolsphytosterolspolysaccharidesseaweed

Identifiers

PMID31719238
PMCPMC6990778
OpenAlexW2986080638

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.